Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2015-12-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.5b01664PMID 26632862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Putative Kappa Opioid Heteromers As Targets for Developing Analgesics Free of Adverse Effects

  2014cited by this paper
• Structure-Based Ligand Discovery Targeting Orthosteric and Allosteric Pockets of Dopamine Receptors

  2013cited by this paper
• Ligands that interact with putative MOR-mGluR5 heteromer in mice with inflammatory pain produce potent antinociception

  2013cited by this paper
• Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.

  2013cited by this paper
• Bivalent ligands that target μ opioid (MOP) and cannabinoid1 (CB1) receptors are potent analgesics devoid of tolerance.

  2013cited by this paper
• MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys

  2012cited by this paper
• Crystal structure of the μ-opioid receptor bound to a morphinan antagonist

  2012cited by this paper
• Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic

  2012cited by this paper
• Fragment Screening at Adenosine-A3 Receptors in Living Cells Using a Fluorescence-Based Binding Assay

  2012cited by this paper
• N-naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers

  2011cited by this paper
• Amino-Functionalized Polyethylene for Enhancing the Adhesion between Polyolefins and Polyurethanes

  2011cited by this paper
• Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands

  2010cited by this paper
• Preparation of FRET reporters to support chemical probe development.

  2010cited by this paper
• Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

  2010cited by this paper
• Opioid receptor internalization contributes to dermorphin-mediated antinociception.

  2010cited by this paper
• Synthesis and Physical Chemistry of s-Tetrazines: Which Ones are Fluorescent and Why?

  2009cited by this paper
• Induced association of mu opioid (MOP) and type 2 cholecystokinin (CCK2) receptors by novel bivalent ligands.

  2009cited by this paper
• Amide bond formation: beyond the myth of coupling reagents.

  2009cited by this paper
• Amide Bond Formation: Beyond the Myth of Coupling Reagents

  2009cited by this paper
• A bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptors.

  2009cited by this paper
• Developments in fluorescent probes for receptor research.

  2009cited by this paper
• Fluorescent labeling of biomolecules with organic probes.

  2009cited by this paper
• Fluorescent GPCR ligands as new tools in pharmacology.

  2008cited by this paper
• Opioid mechanisms and opioid drugs

  2008cited by this paper
• The synthesis and fluorescence of novel N‐substituted‐1,8‐naphthylimides

  2008cited by this paper
• Solid-phase organic tagging resins for labeling biomolecules by 1,3-dipolar cycloaddition: application to the synthesis of a fluorescent non-peptidic vasopressin receptor ligand.

  2008cited by this paper
• Preparation and physicochemical studies of new multiple rings s-tetrazines

  2008cited by this paper
• Peptide-labeled quantum dots for imaging GPCRs in whole cells and as single molecules.

  2007cited by this paper
• New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.

  2007cited by this paper
• Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomes.

  2006cited by this paper
• Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures.

  2006cited by this paper
• New tetrazines substituted by heteroatoms including the first tetrazine based cyclophane : Synthesis and electrochemical properties

  2006cited by this paper
• Separation of μ-Opioid Receptor Desensitization and Internalization: Endogenous Receptors in Primary Neuronal Cultures

  2006cited by this paper
• Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.

  2005cited by this paper
• Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells.

  2005cited by this paper
• Synthesis and properties of new tetrazines substituted by heteroatoms: towards the world's smallest organic fluorophores.

  2005cited by this paper
• Interaction of Bivalent Ligand KDN21 with Heterodimeric δ-κ Opioid Receptors in Human Embryonic Kidney 293 Cells

  2005cited by this paper
• Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells.

  2004cited by this paper
• The orvinols and related opioids--high affinity ligands with diverse efficacy profiles.

  2004cited by this paper
• The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

  2003cited by this paper
• Morphine, the Proteus of organic molecules.

  2002cited by this paper
• μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization

  2002cited by this paper
• Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors.

  2001cited by this paper
• Binding and internalization of fluorescent opioid peptide conjugates in living cells.

  2000cited by this paper
• Synthesis and pharmacological activity of thebaine-derived mu-opioid receptor agonists.

  1999cited by this paper
• Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.

  1998cited by this paper
• A novel chromium trioxide catalyzed oxidation of primary alcohols to the carboxylic acids

  1998cited by this paper
• Synthesis and characterization of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-labeled fluorescent ligands for the mu opioid receptor.

  1997cited by this paper
• Arylacetamide-derived fluorescent probes: synthesis, biological evaluation, and direct fluorescent labeling of kappa opioid receptors in mouse microglial cells.

  1996cited by this paper
• Characterization of the cloned human mu opioid receptor.

  1995cited by this paper
• Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes.

  1995cited by this paper
• Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.

  1994cited by this paper
• Characterisation of μ-opioid receptors on SH-SY5Y cells using naloxonazine and β-funaltrexamine

  1994cited by this paper
• Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine.

  1994cited by this paper
• Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters.

  1993cited by this paper
• Synthesis and characterization of 7-nitrobenzo-2-oxa-1,3-diazole (NBD)-labeled fluorescent opioids.

  1992cited by this paper
• Electrophilic alpha-methylene-gamma-lactone and isothiocyanate opioid ligands related to etorphine.

  1990cited by this paper
• Hybrid bivalent ligands with opiate and enkephalin pharmacophores.

  1987cited by this paper
• Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to mu and delta opiate receptors.

  1986cited by this paper
• Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to μ and δ opiate receptors

  1986cited by this paper
• Delta and mu opiate receptor probes: fluorescent enkephalins with high receptor affinity and specificity.

  1985cited by this paper
• δ and μ opiate receptor probes: fluorescent enkephalins with high receptor affinity and specificity

  1985cited by this paper
• Visualization of enkephalin receptors by image-intensified fluorescence microscopy.

  1983cited by this paper
• Fluorescent probes for opioid receptors.

  1983cited by this paper
• Fluorescent and photo-affinity enkephalin derivatives: preparation and interaction with opiate receptors.

  1979cited by this paper
• Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration.

  1979cited by this paper
• Opiate (Enkephalin) receptors of neuroblastoma cells: occurrence in clusters on the cell surface.

  1979cited by this paper
• Fluorescent enkephalin derivatives with biological activity.

  1978cited by this paper
• Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine.

  1967cited by this paper

• Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonists.

  2025cites this paper
• A Tetrazine‐Based Synthesis for Accessing Underutilized Aza‐Indole Analogues

  2025cites this paper
• The advancing role of fluorogens with AIE characteristics in drug screening

  2024cites this paper
• Pharmacokinetic profile of the synthetic mu-opioid receptor agonist [Lys7]Dermorphin-IRDye®800CW and its feasibility as a biomarker for opioid use disorder

  2023cites this paper
• Detecting and measuring of GPCR signaling – comparison of human induced pluripotent stem cells and immortal cell lines

  2023cites this paper
• The chronological evolution of fluorescent GPCR probes for bioimaging

  2023cites this paper
• A light-up fluorescence probe for wash-free analysis of Mu-opioid receptor and ligand-binding events.

  2023cites this paper
• Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity

  2023influential citation
• Key Aspects of Modern GPCR Drug Discovery.

  2023cites this paper
• Cross‐Coupling‐Cyclocondensation Reaction Sequence to Access a Library of Ring‐C Bridged Pyrimidino‐tetrahydrothebaines and Pyrimidinotetrahydrooripavines

  2021cites this paper
• Design and Application of Receptor-Targeted Fluorescent Probes Based on Small Molecular Fluorescent Dyes.

  2021cites this paper
• Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells.

  2021cites this paper
• Fluorescent opioid receptor ligands as tools to study opioid receptor function.

  2021cites this paper
• Development and Biological Applications of Fluorescent Opioid Ligands.

  2020cites this paper
• New small molecule fluorescent probes for G protein-coupled receptors: valuable tools for drug discovery.

  2020cites this paper
• Cyanine Conjugate‐Based Biomedical Imaging Probes

  2020cites this paper
• Investigation of inactive state κ opioid receptor homodimerization via single molecule microscopy using new antagonistic fluorescent probes.

  2020cites this paper
• Subtype-selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor.

  2019cites this paper
• Fluorescent analogues of BeKm-1 with high and specific activity against the hERG channel

  2019cites this paper
• New Polyfluorinated Cyanine Dyes for Selective NIR Staining of Mitochondria.

  2019cites this paper
• Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells

  2018cites this paper
• Fluorescently Labeled Morphine Derivatives for Bioimaging Studies.

  2018cites this paper
• Fluorescent probes for G-protein-coupled receptor drug discovery

  2018cites this paper
• Endogenous Opiates and Behavior: 2015.

  2017cites this paper